Generic Industry Faces Consolidation As Indian Firms Look To Enter U.S.
Executive Summary
The generic industry will face continued pricing pressure as Indian firms move into the U.S. market, ABN-AMRO Healthcare Banking Director Tommy Erdei told the Generic Pharmaceutical Association Sept. 19
You may also be interested in...
Generic Industry Likely To See Increasing Geographic Diversification – Barr
The generic drug industry has myriad reasons to expand into non-U.S. markets and will continue to do so, according to Barr CEO Bruce Downey
Generic Industry Likely To See Increasing Geographic Diversification – Barr
The generic drug industry has myriad reasons to expand into non-U.S. markets and will continue to do so, according to Barr CEO Bruce Downey
Generic Industry Likely To See Increasing Geographic Diversification - Barr
The generic drug industry has myriad reasons to expand into non-U.S. markets and will continue to do so, according to Barr CEO Bruce Downey